Onconova Therapeutics and Pangea Biomed Enter into Research Collaboration to Identify Biomarkers of Response to Rigosertib

Onconova Therapeutics and Pangea Biomed collaborate to leverage Pangea’s ENLIGHT platform in identifying biomarkers of response to Onconova’s cancer drug candidate rigosertib.